Cloud Banner

Healthcare

Image

Global Travel Vaccine Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Aug 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Travel Vaccine Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - 11.600000000000001% Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 3.20 Billion
Diagram Market Size (Forecast Year) USD 7.70 Billion
Diagram CAGR 11.600000000000001%

Global Travel Vaccine Market, By Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others)– Industry Trends and Forecast to 2029.

Travel Vaccine Market Analysis and Size

A biological preparation known as a vaccination offers active acquired protection to a specific infectious disease. A vaccination often comprises a substance that resembles a germ that causes a disease, this substance is frequently created from a bacteria's weaker or dead forms, its toxins, or one of its surface proteins.

Data Bridge Market Research analyses that the travel vaccine market which was USD 3.2 billion in 2021, would rocket up to USD 7.70 billion by 2029, and is expected to undergo a CAGR of 11.6% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Travel Vaccine Market Scope and Segmentation      

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

GSK plc (U.K.), Sanofi (France), Merck KGaA (Germany), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Bavarian Nordic (Denmark), Janssen Pharmaceuticals Inc. (U.S.), CSL Limited (Australia), AstraZeneca (U.K.), Altimmune (U.K.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Crucell (Netherlands)

Market Opportunities

  • Improved preference for automated travel vaccine practices
  • Increasing disposable incomes stimulate demand

Market Definition

Travel vaccinations, commonly referred to go vaccines, are shots that people can have before they travel to specific parts of the world to help prevent them from deadly infections. Travel vaccinations function by exposing the body to a bacterium or specific components of the pathogen that causes the sickness they are intended to prevent.

Travel Vaccine Market Dynamics

Drivers

  • Increase in cases of flu

The flu part for the most comprehensive travel vaccine business serving is estimated based on the target virus. That was largely attributable to the enormous number of cases of influenza that were accounted for throughout the forecast period and the segment will continue to control the market.

  • Increase in costs for vaccination

Travel-related viruses like hepatitis, tetanus, Japanese encephalitis, meningitis, and yellow fever are becoming more widespread all over the world. This would significantly increase the costs associated with the development of more effective vaccinations, opening up new market opportunities for travel vaccines throughout the forecast period of 2022 to 2029.

  • Rising number of vaccines

Global arrivals of foreign visitors surged from 1.0 billion in 2012 to about 1.4 billion in 2018. Many of these tourists travel from rich nations to places where endemic diseases are prevalent. The need for vaccines will rise as more individuals travel to nations where certain diseases are widespread.

Opportunities

In the evolution of infections, more human contact with various invertebrates and plants has also emerged. This helps vaccine businesses finance research and development initiatives to create fresh, improved, and effective vaccines that will increase the market's expansion potential.

Restraints/Challenges

Due to some market limitations, it can be difficult to stock travel vaccines at an ambiguous temperature. Certain room conditions are necessary for vaccinations. There are many different medical histories. Resuming the vaccination schedule after puberty may have additional negative effects.

This travel vaccine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the travel vaccine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Travel Vaccine Market

Regulations and advice relating to travel vaccines mostly addressed infectious diseases prior to the COVID-19 pandemic of 2020. However, they revealed a discrepancy among travellers, with some choosing not to get immunised owing to cost, lack of knowledge, and personal preference. Examples of this include travellers visiting friends and relatives and casual travellers. Numerous endemics and international illnesses resulted from this. The COVID-19 epidemic has substantially impacted the world's health economies and put enormous pressure on the global travel vaccine market.

Global Travel Vaccine Market Scope

The travel vaccine market is segmented on the basis of composition and disease. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Composition

  • Mono Vaccines
  • Combination Vaccines

 Disease

  • Hepatitis A
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Varicella
  • Japanese Encephalitis
  • Others

Travel Vaccine Market Regional Analysis/Insights

The travel vaccine market is analysed and market size insights and trends are provided by country, composition and disease as referenced above.

The countries covered in the travel vaccine market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominate the travel vaccine market due to the constant updates on traveling safety, crises, epidemic brawls, and concerns associated with vaccine stocks in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced vaccines.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Travel Vaccine Market Share Analysis

The travel vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to travel vaccine market.

Some of the major players operating in the travel vaccine market are:

  • GSK plc (U.K.)
  • Sanofi (France)
  • Merck KGaA (Germany)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (U.S.)
  • Bavarian Nordic (Denmark)
  • Janssen Pharmaceuticals Inc. (U.S.)
  • CSL Limited (Australia)
  • AstraZeneca (U.K.)
  • Altimmune (U.K.)
  • Abbott (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Crucell (Netherlands)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The travel vaccine market value is projected to 7.70 billion USD by 2029.
The travel vaccine market is projected to grow at a CAGR of 11.6% during the forecast period of 2022-2029.
The major players operating in the Travel Vaccine Market are GSK plc (U.K.), Sanofi (France), Merck KGaA (Germany), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Bavarian Nordic (Denmark), Janssen Pharmaceuticals Inc. (U.S.), CSL Limited (Australia), AstraZeneca (U.K.), Altimmune (U.K.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Crucell (Netherlands).
The major countries covered in the Travel Vaccine Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials